Healthtech & Wellness VC Funds

Cathay Innovation, founded in 2015, is a global venture capital firm affiliated with Cathay Capital. The firm focuses on multi-stage investments in innovative startups across various sectors, including AI, fintech, digital health, consumer tech, and energy. With a presence in North America, Europe, Asia, and Latin America, Cathay Innovation leverages its global network to support entrepreneurs in scaling their businesses. Notable investments in Cathay Innovation's portfolio include Ledger, a leading provider of blockchain-based hardware wallets for cryptocurrency, and Glovo, a Spanish on-demand delivery service that was acquired by Delivery Hero. Other significant investments are Owkin, which uses AI for drug discovery and precision medicine, and Kredivo, a fintech company providing consumer loans in Indonesia. The firm has also seen several successful exits, such as the IPO of Wallbox, a smart charging company listed on the New York Stock Exchange, and the acquisition of Getaround, a peer-to-peer car sharing service. Cathay Innovation has a strong track record of identifying and nurturing high-growth companies, with multiple portfolio companies achieving unicorn status. Led by a diverse team of 45 members, including 17 partners, Cathay Innovation emphasizes a collaborative approach, providing strategic support and leveraging its extensive ecosystem to help startups thrive globally. The firm continues to drive innovation and positive impact through its investments in technology-driven companies.

Cathexis Ventures is a venture capital firm based in Houston, Texas, and serves as the venture arm of Cathexis Holdings. Established in 2018, Cathexis Ventures has a diverse investment portfolio with over 100 companies. They primarily focus on seed-stage investments but also participate in pre-seed and Series A rounds. Their investment strategy includes an 80% focus on seed, 10% on pre-seed, and 10% on Series A investments, with initial check sizes ranging from $250,000 to $1,000,000, and up to eight-figure follow-on investments. The firm invests across various sectors, including SaaS (60%), hardware (30%), and consumer (10%) products, with a geographic focus of 70% in North America and 30% internationally. Notable investments include companies like Betterhalf, an AI-enabled matchmaking platform, and BlueCargo, which focuses on smarter container movement. Other significant investments span industries such as healthcare compliance (Verifiable), construction operations (Tenderd), and carbon capture technology (Heimdal). Cathexis Ventures is led by a team of experienced investors and professionals who aim to support extraordinary founders building innovative products with speed and efficiency.

CDP Venture Capital is a leading venture capital firm based in Italy, launched with the goal of accelerating the country's innovation ecosystem. It operates as part of the National Innovation Fund (Fondo Nazionale Innovazione), with the primary aim of fostering the growth of startups across various sectors, including deep tech, medtech, biotech, digital, and more. The firm is driven by the mission to shape Italy's future by investing in high-potential businesses that are transforming strategic industries. CDP manages over €1 billion in assets and works to make venture capital a key pillar of Italy's economic development. The firm invests at various stages, from pre-seed and seed funding to Series A and beyond, with typical investments ranging between €1.5 million and €3 million. Their portfolio includes promising startups such as Empatica, GreenBone, and Mindesk, and they collaborate with national agencies and international partners to support Italy's entrepreneurial growth. A key initiative of CDP Venture Capital is its focus on technology transfer, helping bridge the gap between academic research and commercial success. The firm also actively promotes innovation in areas like AI, web 3.0, and cybersecurity, and it plays a critical role in positioning Italy as a hub for high-tech startups.

CE Venture Capital (CE Ventures / CEIIF — CreditEase Israel Innovation Fund) is a venture capital fund established in 2015, managed by Israel Innovation Investment Management Ltd. and headquartered in Hong Kong. The fund was co-founded by Tayman Kan and Benjamin Weiss, raising $30 million at its first close in October 2015, backed by clients of CreditEase China — a national leader in wealth management, credit management, microfinance, and microcredit services. The fund's strategic premise connects Israeli technological innovation with the distribution and market access advantages of CreditEase's extensive China-region network. The fund deploys $500,000 to $3 million per deal, investing at the Seed through Series B stages across 33 portfolio companies in Israel and the United States. Focus sectors include information technology, telecommunications, healthcare, smart materials, and media. Notable portfolio companies include Corephotonics, a dual-camera technology company acquired by Samsung Electronics for approximately $155 million in January 2019; Saguna Networks in edge computing; and Silentium in active noise cancellation. Peak investment activity was concentrated in 2017 with peak exits in 2019. The fund's value proposition is built on geographic arbitrage: Israeli founders gain access to CreditEase's Chinese market relationships for sales acceleration, strategic partnerships, and production efficiency. This China-access model was a genuine differentiator during the fund's active period, offering portfolio companies a commercial bridge that conventional venture capital investors based in Israel or the United States were not positioned to provide.

Cencora Ventures, formerly known as AB Health Ventures, is the corporate venture arm of Cencora (previously AmerisourceBergen). Launched in 2022, the $150 million fund focuses on investing in early-stage healthcare startups that aim to transform the future of healthcare for both humans and animals. By leveraging Cencora's vast experience and resources, Cencora Ventures offers more than just capital; it actively supports startups with commercialization, distribution, and scalability. The fund is deeply integrated with Cencora’s global pharmaceutical supply chain, allowing it to facilitate connections with healthcare providers, pharmacies, and biotech firms. Cencora Ventures' portfolio includes companies such as SteadyMD, a telehealth infrastructure provider, and Trakcel, which offers solutions for cell and gene therapy orchestration. The fund focuses on areas like digital health, patient management, and decentralized clinical trials, aiming to improve healthcare delivery and outcomes across the globe. With a presence in over 50 countries, Cencora Ventures leverages its parent company’s global network to accelerate the growth of its portfolio companies, offering strategic support such as pilot programs, rapid prototyping, and introductions to a broad customer base. This integration helps emerging companies scale their innovations more efficiently while navigating the complex healthcare ecosystem​.

Centicorn Ventures is a Singapore-based venture capital firm founded in 2018, operating on the FEBE model — For Entrepreneurs, By Entrepreneurs. The firm was established by entrepreneurs and senior executives to provide seed and early-stage growth capital to founders across the Asia-Pacific region. Sector-agnostic in approach, Centicorn has particular interest in information technology, manufacturing, healthcare, and consumer products and services. The firm invests primarily at the Seed stage with potential follow-on at Series A, writing checks of $100,000 to $1 million. Across 12 portfolio investments, the firm covers software applications, healthtech, and consumer goods. Investment committees are composed of top industry practitioners from each relevant sector, who both evaluate deal quality and add hands-on value to portfolio companies post-investment — a structure designed to blend institutional rigor with operator insight. Centicorn Ventures maintains a relatively low public profile for a Singapore-based venture firm, with limited published detail about specific portfolio companies, total fund size, and team composition beyond its FEBE model and sector interests. The firm focuses on the broader Asia-Pacific market from its Singapore base, targeting the region's growing cohort of ambitious technology founders who benefit from investors with direct operating experience in their respective industries.

CDTI (Centro para el Desarrollo Tecnológico Industrial) is a Spanish public business entity under the Ministry of Science and Innovation. It supports technological development and innovation within Spain, mainly by channeling financial and technical assistance to companies working on R&D&I projects. One of its key initiatives, Innvierte, is a venture capital program designed to foster investment in innovative, high-tech startups. Through Innvierte, CDTI co-invests with private capital in technology-based enterprises, targeting sectors like biotech, fintech, artificial intelligence, and digital media. The program has committed over €450 million to co-investment projects and venture capital funds, positioning itself as a critical player in Spain’s innovation ecosystem. CDTI has been involved in significant rounds of funding for companies like Atani, Bdeo, and Odilo. CDTI’s investment approach focuses on supporting early-stage companies with disruptive potential, aiming to bridge the gap between innovation and commercialization. This public-private partnership strategy helps drive Spain’s technology transfer and entrepreneurial growth, supporting industries crucial to the country's economic future.

Centre Street Partners, founded in 2015 and based in New York, focuses on early-stage investments in the technology sector. Their investment strategy targets companies that develop frontier technologies for a rapidly evolving world. Notable investments include Drunk Elephant, Briogeo Hair Care, and Parade, all of which have seen successful exits. The firm invests primarily in the information technology sector, with a diverse portfolio that includes companies like OffDeal, Scream Truck, and Arcee.ai. Centre Street Partners typically invests in seed and early-stage rounds, supporting companies with innovative and scalable solutions. The team is led by General Partners Abie Cohen and Jonathan Kerstein, who bring significant expertise and experience to the firm. Centre Street Partners is committed to partnering with ambitious founders and providing the necessary resources to help their portfolio companies grow and succeed.

CentreStone Ventures is a life sciences-focused private venture capital fund founded in 2004 and based in Winnipeg, Manitoba, Canada — geographically at the center of North America. The firm invests in companies developing early-stage therapeutics, medical devices, diagnostics, and novel drug delivery methods, targeting opportunities with clear unmet clinical needs, solid intellectual property foundations, and the potential to achieve market leadership. CentreStone deploys checks of $500,000 to $3 million at the Seed and Series A stages. Across seven portfolio investments, the firm has achieved three IPOs and one acquisition — a strong exit rate relative to portfolio size that reflects a selective, high-conviction approach to company selection. The small team of three manages a focused book of life sciences companies, prioritizing depth of engagement over breadth of portfolio. The firm appears to be in portfolio management mode rather than actively making new investments, with the most recent investment recorded in 2018. During its active period, CentreStone played a niche institutional role in Canada's healthcare and biotech ecosystem — channeling specialized venture capital into a region that generates significant life sciences research through its university and medical community but has historically had limited access to dedicated early-stage health technology investment capital.

Ceras Ventures is a global investment firm focusing on disruptive startups, particularly in the fast-growing areas of Web 3.0, blockchain, and decentralized technologies. Established in 2020, Ceras Ventures has rapidly built a portfolio of over 70 projects, with investments totaling $100 million. Their focus spans several key sectors, including decentralized finance (DeFi), Web 3.0 infrastructure, AI-powered protocols, and blockchain-based assets like Real World Assets (RWA). The firm’s investment philosophy revolves around creating long-term value and capital appreciation by backing innovative projects that are shaping the future of the digital economy. Ceras Ventures supports projects that incorporate decentralization to improve data security, access, and ownership, while also fostering transparency and financial inclusion. The firm’s diverse portfolio includes investments in blockchain gaming, NFTs, DeFi platforms, and AI-integrated technologies, all aimed at revolutionizing the way digital ecosystems operate. With a clear mission to help innovative projects achieve their full potential, Ceras Ventures partners closely with founders, offering not just capital but strategic guidance to grow within the blockchain and Web 3.0 space.

Cercano Management is a venture capital firm spun out from Vulcan Capital, originally established by Microsoft co-founder Paul Allen. Based in Bellevue, Washington, with a new office in Atlanta, the firm focuses on early-stage investments across sectors like technology, consumer, life sciences, and data intelligence. With a patient and methodical approach, Cercano has over two decades of investment experience, boasting a diverse portfolio of more than 120 companies. The firm is particularly active in both the West Coast and Southeast U.S., with an increasing presence in Atlanta to capitalize on early-stage opportunities in emerging markets. Key investments include Group14 Technologies, AdaptX, and Twelve, demonstrating their strong interest in transformative technologies and sustainability ventures. Cercano’s strategy revolves around long-term partnerships, often leading early rounds but maintaining flexibility to support companies through later stages. Their average check size varies, but they are known to lead or co-lead rounds, particularly in seed and Series A investments. Startups looking to engage with Cercano should prioritize demonstrating innovative solutions and a strong growth trajectory. The team, led by CEO Christopher Orndorff and supported by leaders like Daley Ervin in Atlanta and Tommy Teo in Singapore, offers global insights with a deep expertise in scaling tech companies.

Ceres Venture Fund, L.P. was a Chicago-area venture capital fund founded in 2005 by Laura Pearl, based in Northfield, Illinois. The fund dedicated itself to backing high-growth companies in the Midwest during their early stages of development, operating from the conviction that early-stage businesses in the region represented an attractive and underserved pool of investment opportunities relative to their coastal counterparts. The fund was affiliated with The Chicago Network and targeted healthcare, information technology, and business services as its primary industry verticals. Ceres deployed checks of $500,000 to $3 million at the Seed and Series A stages across 18 portfolio investments. The fund sought entrepreneurs with proven capabilities and the ambition to build category-leading companies, pairing capital with resources and strategic guidance. Laura Pearl's leadership brought institutional discipline to the Midwest venture capital market during a period when dedicated early-stage capital in the region was limited. The fund is now liquidated and no longer actively operating. During its active period, Ceres Venture Fund contributed to the development of the Chicago-area startup ecosystem, channeling early institutional capital into healthcare and technology companies at a time when the Midwest venture landscape was considerably thinner than it is today. The fund's exits and outcomes are not publicly detailed in available data, but its 18-company portfolio reflects a decade of consistent early-stage investment activity across the region.

CerraCap Ventures, based in Costa Mesa, California, is a global venture capital firm focused on early-stage B2B technology companies. Their key sectors are health tech, enterprise AI, and cybersecurity. Using their unique Sales & Scale™ model, they guide startups through an industrialized process designed to accelerate sales, scale product development, and facilitate successful exits. CerraCap leverages an extensive network of Fortune 500 CXOs to secure early proofs of concept and streamline product adoption. Their investment strategy is geared toward companies that solve real-world problems in healthcare and digital security, with a focus on chronic disease management and securing digital environments. Some notable portfolio companies include Deep Instinct and Dathena, specializing in cybersecurity through AI-driven solutions. CerraCap often leads rounds and provides hands-on support to help startups achieve growth, reduce sales cycles, and gain traction with key customers. The team, led by co-founders Saurabh Ranjan and Saurabh Suri, draws on years of industry expertise to mentor and position companies for success in global markets​.

FinTech Venture Capital is dedicated to investing in innovative financial technology companies at various stages of growth. Their investment strategy spans pre-seed, seed, Series A, and Series B rounds, with a focus on supporting startups that offer disruptive solutions in the fintech space. Notable investments by FinTech VC include high-profile companies such as Stripe, a leader in online payment processing, and Affirm, a prominent player in the buy-now-pay-later market. Other significant investments include SoFi, a personal finance company that offers student loan refinancing, mortgages, and personal loans, and Nubank, a digital bank based in Brazil that has revolutionized banking in Latin America. FinTech VC's portfolio reflects a strong commitment to fostering growth in companies that leverage technology to improve financial services and infrastructure. They provide not only capital but also strategic support and industry expertise to help their portfolio companies scale effectively and achieve significant market impact.

Chaac Ventures is an early-stage venture capital firm founded in 2015 by Luke Armour and based in Santa Monica, California. The firm primarily focuses on investing in companies founded by Princeton University alumni, leveraging the global Princeton tech and innovation ecosystem. With a focus on sectors like software, cybersecurity, AI, healthcare, and SaaS, Chaac Ventures actively supports startups during their seed and early growth phases. The firm has a track record of investing in notable companies such as Overtime, an innovative sports media company, and Create/OS, a music industry platform. Chaac Ventures typically invests between $1 million and $5 million and aims to drive the next generation of visionary entrepreneurs. Their portfolio also includes companies like Auxa Health and PIXM, which are focused on healthcare and cybersecurity, respectively. With Luke Armour leading the firm as Managing Partner, Chaac Ventures remains committed to fostering innovation and supporting founders from the Princeton community, helping them scale and expand globally.

Chalmers Ventures is a leading Nordic technology investor and venture builder based in Gothenburg, Sweden, founded in 1997. Situated at the core of the entrepreneurial ecosystem of Chalmers University of Technology, the firm transforms breakthrough research into successful, impact-driven companies — combining venture creation and investing under a single roof. The firm operates an evergreen investment model, reinvesting returns into new ventures rather than returning capital on a fixed fund cycle, supporting startups from lab to market with coaching, funding, and network access across Scandinavia and Europe. Chalmers Ventures has invested in approximately 193 companies, deploying checks from SEK 1 million (approximately $100,000) at pre-seed to SEK 25 million (approximately $2.5 million) for growth capital, spanning Pre-seed through Series A stages. The firm specializes in deep tech investments across green tech, information technology, communications, new materials, and health technology. Investment sectors include cleantech and sustainability, AI, healthtech, hardware and robotics, and software — with cleantech and AI each representing more than 35 investments. As an impact investor anchored to one of Europe's leading technical universities, Chalmers Ventures operates with a dual mandate: generating financial returns and creating measurable societal impact. The firm's role as a venture builder — not just a passive capital allocator — means it actively co-develops companies from research findings, giving it a structural advantage in identifying breakthrough technologies before they are visible to the broader venture market.

Chamaeleon is an early-stage VC firm headquartered in Silicon Valley, investing globally in transformative startups. Their proprietary AI-driven engine, Mantis, is at the core of their strategy, enabling them to analyze massive data sets for high-quality deal sourcing, risk assessment, and portfolio management. This data-first approach gives them a competitive edge, spotting emerging trends faster than others. Their focus is on B2B startups, particularly in SaaS, cybersecurity, and cloud infrastructure, making significant bets in companies like Mysten Labs, Draft Kings, Robinhood, and Rubrik. Chamaeleon typically invests in Seed and Series A rounds and is not shy about leading investments. They maintain strong networks across the U.S. and Europe, especially with key players in cloud and enterprise tech. Co-founded by Alexandre Santos, the firm blends decades of experience in tech and corporate venture building, supporting portfolio companies with both capital and operational insights. The firm prefers working with founders who share their commitment to large-scale impact and often builds relationships through referrals within their extensive network. While they handle investments efficiently through their tech, human judgment remains integral in critical decisions. Chamaeleon’s distinct combination of data science and traditional VC expertise has led to top-tier returns, placing them in the top 2-5% of investors globally.

Chang.com, led by renowned angel investor Wayne Chang, focuses on investing in early-stage tech companies with high-growth potential. With a strong presence in Boston, Chang's portfolio spans over 80 startups, including notable names like DraftKings, Dropbox, and FaZe Clan. Known for identifying the "next big thing" in the digital world, Wayne Chang's investments span various industries, from SaaS to e-sports and fintech. Chang typically targets Seed to Series A rounds, making substantial contributions to companies that are already generating revenue. Chang's investment strategy hinges on backing founders with a strong vision and disruptive potential. The firm has built a solid track record with multiple high-profile exits and IPOs, including Twitter’s acquisition of Crashlytics, which was one of its largest purchases. Chang operates both in the U.S. and globally, and the firm's investments are concentrated in areas like media, productivity software, and cloud services. Startups looking to catch Chang’s attention would benefit from a strong product-market fit and impressive early-stage traction. With his hands-on approach and deep connections in the venture ecosystem, Wayne Chang actively supports his portfolio companies through key phases of growth. His reputation as an angel investor with top-tier exits makes him a go-to for founders seeking both capital and strategic advice.

Change Ventures, founded in 2016 and headquartered in Tallinn, Estonia, is a leading venture capital firm focused on early-stage investments in the Baltic region. The firm has built a strong portfolio with notable investments in companies such as Formaloo, a software development applications firm, and RivalSense, a business productivity software company. They emphasize supporting ambitious Baltic founders across various sectors including aerospace, defense, and hospitality. Change Ventures has made 59 investments to date, demonstrating their commitment to nurturing innovative startups. They have seen successful exits, including Nordigen, a company acquired in 2022. The firm's investment strategy is centered around providing not only capital but also mentorship and strategic guidance to help startups scale effectively. The team at Change Ventures includes experienced professionals like Andris Berzins, who has held C-level roles in successful startups and co-founded TechHub Riga and TechChill. Other key members include Yrjö Ojasaar, a seasoned tech-startup CEO and angel investor, and Rait Ojasaar, an experienced tech entrepreneur and mentor. This diverse team brings a wealth of expertise and a deep understanding of the startup ecosystem in the Baltic region. By leveraging their extensive network and deep industry knowledge, Change Ventures continues to play a pivotal role in the growth and success of early-stage startups in the Baltics​.

Chaos Ventures, founded in 2020 and headquartered in New York, is an early-stage venture capital firm that invests in transformative industries leveraging emerging technologies. The firm focuses on sectors such as financial services, healthcare, and consumer markets, with a particular interest in technologies like blockchain, artificial intelligence (AI), machine learning (ML), virtual reality, and quantum computing. By targeting these cutting-edge technologies, Chaos Ventures seeks to back companies that are poised to disrupt traditional industries and reshape how we live, work, and interact with technology. Chaos Ventures has deployed over $40 million in capital across more than 80 investments. Its portfolio includes companies such as Figure Technologies, a blockchain-based financial services firm, Candy Digital, an NFT platform for Major League Baseball fans, and Uala, a fintech startup offering a financial ecosystem linked to a free Mastercard​. The firm is known for taking an active role in supporting its portfolio companies, leveraging a wide network of industry experts, investors, and strategic partners to help startups grow and navigate challenges​. Led by experienced partners like Justin Smith and Ryan Alexander, Chaos Ventures brings together a diverse community of technology entrepreneurs, professional athletes, and industry executives. Their collective expertise spans venture capital, private equity, and leadership roles at major companies such as Uber and Afiniti​. Chaos Ventures aims to turn the "chaos" of startup life into opportunity, providing the guidance and resources that early-stage companies need to scale and thrive.

Charge Ventures, founded in 2015 and based in New York City, is a venture capital firm that focuses on early-stage investments. The firm typically invests in startups operating in sectors like business productivity software, multimedia and design software, social and platform software, and healthcare. Charge Ventures has a diverse portfolio that includes companies such as Transfix, a marketplace for on-demand load matching and freight booking services; Livepeer, a decentralized live video streaming platform; and Electric, an IT management software company that achieved unicorn status. Other notable investments include Parsley Health, a data-driven medical practice offering personalized healthcare, and GRIN, a platform for influencer marketing solutions. The firm has made 86 investments and achieved 15 exits, including Bulletin, SimpleHealth, and Podz. Charge Ventures is led by co-founders and general partners Brett Martin and Chris Habachy, who bring extensive experience and a strategic approach to supporting their portfolio companies' growth and success.

Chartline Capital Partners, based in Wilmington, Delaware, is a venture capital firm focused on B2B technology companies. Founded in 2012 by Benjamin duPont and Phillip Stern, Chartline invests in enterprise and industrial technology companies that improve efficiency, reliability, and safety across core industries. The firm specializes in scaling companies that have already achieved a strong go-to-market strategy, with annual revenues of $3-5 million. Chartline typically invests between $500K and $5 million, supporting its portfolio companies with strategic introductions and customer connections to accelerate growth. Chartline focuses on sectors such as HR Tech, Financial Technology, Property Technology, and Digital Industrials, providing capital and expertise to companies looking to scale in these areas. Notable investments include PowerToFly, Gig Wage, and Humi, all of which are involved in business productivity and financial services. Chartline's investment approach emphasizes strategic focus, operational cadence, and strong governance to help companies thrive and scale effectively. Led by experienced entrepreneurs and investors, including co-founder Ben duPont, Chartline is known for its commitment to improving corporate governance and maintaining high standards of fiduciary responsibility. The firm seeks to foster strong partnerships with founders and management teams, helping them navigate growth and operational challenges while ensuring long-term success.

Chattanooga Renaissance Fund (CRF) is a formalized angel capital fund based in Chattanooga, Tennessee, dedicated to fostering entrepreneurship and economic growth within the region. Established with the mission of supporting local startups, CRF invests primarily in seed and early-stage companies that exhibit strong growth potential and solid business habits. The fund emphasizes mentorship and consistent support throughout the investment process to ensure the success of the businesses they back. CRF's notable investments include companies such as Collider, SupplyHog, and RentStuff.com. These investments highlight the fund's focus on innovative startups that can drive significant economic impact in Chattanooga and the surrounding areas. CRF's strategy is deeply rooted in leveraging the region's rich technological infrastructure, including the computational Simulation Center at UTC and the EPB-powered gigabit fiber network, to nurture and scale high-potential ventures. The fund is managed by a team of experienced professionals who provide not only financial support but also strategic guidance and access to a robust network of mentors and industry experts. This comprehensive approach helps startups navigate early-stage challenges and accelerates their path to growth and success

Checkmate Capital is a venture capital and strategic advisory firm based in Pasadena, California, with a global reach, including a presence in Seoul, South Korea. Founded in 2017, Checkmate Capital focuses on investments in biotechnology, agriculture and waste technology, energy technology, and diversified technologies. The firm is deeply involved in the sectors it invests in, offering both financial backing and strategic advisory services to help companies grow and succeed. Checkmate Capital's portfolio spans a wide range of industries, including high-tech areas like biotechnology, where they invest in companies developing innovative health solutions, and energy technology, focusing on environmentally friendly and efficient energy solutions. The firm prides itself on its disciplined approach to investment, working closely with companies to create synergies that enhance value across its portfolio. In addition to its investment activities, Checkmate Capital also provides commercial and transaction advisory services, facilitating international licensing opportunities and partnerships that help its portfolio companies expand globally.

Cherry Ventures, founded in 2012, is an early-stage venture capital firm based in Berlin, with additional offices in London and Stockholm. The firm primarily invests in pre-seed and seed-stage startups across various sectors, including fintech, climate tech, consumer products, health tech, mobility, and SaaS. Cherry Ventures is led by partners Filip Dames, Christian Meermann, and Sophia Bendz, all of whom have extensive entrepreneurial experience from building companies like Zalando and Spotify. The firm recently launched its fourth fund at €300 million, focusing on disruptive technologies including crypto and web3. Notable portfolio companies include Infarm, AUTO1 Group, FlixBus, TWAICE, and Cazoo.

Cherubic Ventures is a venture capital firm that specializes in early-stage investments, focusing on transformative industries in both the US and Asia. With over $400 million in assets under management, the firm has a portfolio that includes more than 150 startups. Notable investments include Flexport, Hims & Hers, Calm, Ring, Wish, and Paidy, showcasing their ability to identify and support high-growth potential companies. Founded in 2014 by Matt Cheng, Cherubic Ventures operates from key locations in San Francisco, Taipei, and Beijing. Their investment strategy targets seed-stage companies that have the potential to disrupt industries. They typically invest in sectors such as fintech, health tech, consumer internet, and enterprise software, aiming to back ambitious founders from the earliest stages. Cherubic Ventures is known for its hands-on approach, providing more than just capital. They offer strategic guidance and support to help startups scale. Their active involvement in their portfolio companies has led to successful exits, including high-profile acquisitions and IPOs. The firm’s geographic focus allows them to bridge the gap between Western and Asian markets, providing unique opportunities for startups to expand globally. Cherubic Ventures' team is composed of experienced investors and entrepreneurs who leverage their extensive networks to help startups succeed.

Chicago Ventures is a venture capital firm based in Chicago, focusing on seed-stage investments in technology companies. The firm leads early rounds, often stepping in when other investors might overlook startups. Chicago Ventures has invested in over 100 companies, raising significant follow-on capital since its inception in 2012. Prominent companies in their portfolio include Cameo, SpotHero, project44, and G2. Cameo is known for its personalized celebrity video messages, SpotHero for its parking reservation service, project44 for its logistics technology, and G2 for being the largest software marketplace globally. Other notable investments include HealthJoy, a healthcare guidance platform, and Kin, which simplifies homeowners insurance. Chicago Ventures recently closed its third fund, raising $63 million to continue backing startups that might be initially passed over by other investors. They typically invest between $1.5 million to $2 million per startup and aim to make 25 new investments with this fund. The firm's investment strategy emphasizes a hands-on approach, taking board seats and actively supporting the companies in their portfolio. This approach helps startups navigate their early growth stages and scale effectively.

ChileGlobal Ventures is the venture capital arm of Fundación Chile, founded in 2008 and based in Vitacura, Santiago. The firm manages approximately $20 million in assets under management, structured as a fund co-invested by private capital — including Zoma Capital, Entel, and Engie Factory — alongside 67% public leverage from Corfo, Chile's national economic development agency. ChileGlobal Ventures has invested in 72 companies, primarily at the Seed and Series A stages in Chilean startups with a focus on companies that can scale from Chile to broader Latin American and global markets. The firm leads rounds, deploying checks of up to $1 million across software, cleantech, agritech, healthtech, food technology, energy, and biotech. The investment thesis focuses on impact innovations in high-potential sectors for Chile and Latin America, backed by entrepreneurs working on disruptive solutions. Operations run through four pillars: an Impact Finance Network investing in startups, a mentor network, Club CGV providing strategic service providers, and corporate linkage models connecting large companies with innovative startups. ChileGlobal Ventures positions itself as more than a capital provider — the Fundación Chile parentage gives portfolio companies access to an extensive research, technical, and policy network built across decades of work in Chile's priority economic sectors including agriculture, aquaculture, mining, and clean energy. Leadership includes Jaime Riggs and Manuel Rodríguez, who guide a portfolio designed to generate returns while building Chile's long-term innovation capacity.

Chingona Ventures, founded in 2019 by Samara Hernandez and based in Chicago, focuses on early-stage investments, particularly in startups led by women and minorities. The firm emphasizes sectors such as fintech, food technology, health tech, wellness, and the future of work and learning. Chingona Ventures has made significant investments in companies like Career Karma, EarlyBird, and Suma Wealth. The firm recently closed a $52 million Fund II, with contributions from prominent partners including PayPal Ventures and Melinda Gates’ Pivotal Ventures. This fund allows them to increase their typical investment size to between $250,000 and $1 million. The firm is known for backing founders who are often overlooked and operates primarily in the Midwest. Their mission is to support innovative solutions and diverse leadership in the tech industry. The leadership team, including Senior Advisor Sonia Nagar and Associate Grisel Hernandez, brings extensive experience in venture capital and strategic guidance.

Chiratae Ventures — formerly IDG Ventures India, rebranded in 2018 — is one of India's oldest and most prominent technology venture capital firms. Founded in 2006 by Sudhir Sethi and T.C.M. Sundaram as the Indian arm of IDG Ventures, the firm is headquartered in Bangalore with additional offices in Mumbai and New Delhi. With $1.3 billion in assets under management across seven funds, Chiratae has made 130-plus investments, achieved 56 exits, backed 8 unicorns, and witnessed 4 IPOs across its 18-year history. The firm leads rounds from Seed through Series C and beyond, deploying checks of $1 million to $30 million with an average of $8 million per deal. The portfolio spans AI and deep tech, healthtech, fintech, SaaS, e-commerce, and climate technology. Notable portfolio companies include Myntra, the fashion e-commerce platform acquired by Flipkart; Lenskart, a unicorn eyewear brand; PolicyBazaar, which completed an IPO; CureFit/CultFit in health and fitness; FirstCry, which went public; and Bounce in mobility. Founder and Chairman Sudhir Sethi and Vice Chairman TC Meenakshisundaram bring a combined operating and investing background that shapes the firm's partnership approach. Partners Ranjith Menon and Karthik Prabhakar complete the senior team. Chiratae's investment thesis centers on disruptive technologies aligned with emerging Indian market trends — a mandate that has proven durable across multiple technology cycles and produced one of the strongest track records in Indian venture capital.

Chord Capital is a UK-based venture capital firm focused on growth capital investments in early and mid-stage technology companies. It primarily invests in sectors such as clean technology, environmental solutions, and medical devices, while also targeting industries like enterprise software, telecommunications, and engineering. The firm supports startups in commercializing new technologies, with typical investments ranging from £500K to £2M. Chord Capital’s approach combines direct investments with advisory services for third-party funds, focusing on technology-driven opportunities. Notable investments include companies like Metalysis and Vantix Diagnostics, showcasing its emphasis on innovative, high-tech solutions. The firm is headquartered in Kettering, with additional offices in Cambridge and London, positioning itself as a key player in the UK's venture capital ecosystem. Their investment strategy is particularly geared toward companies with strong intellectual property and commercial potential, often entering at the Series A stage​.

Chrysalis Ventures is a Louisville-based venture capital firm focused on early-stage and growth investments, particularly in the Midwest and Southeast U.S. Since its founding in 1993, Chrysalis has managed over $400 million and invested in more than 70 companies. Their primary focus is on healthcare, technology, and media sectors, where they target businesses that can benefit from applying new technologies to accelerate growth. Chrysalis looks for companies with proven business models, usually generating $1 million or more in revenue, and partners with strong management teams that can drive both organic growth and strategic acquisitions. Their hands-on approach extends beyond providing capital; Chrysalis actively supports its portfolio companies with operational insights and growth strategies. The firm prefers investments in fragmented industries where they can help consolidate through roll-ups or acquisitions. With a regional focus, Chrysalis primarily invests in areas underserved by traditional venture capital, aiming to bring technology-driven innovation to businesses in Mid-America. Notable companies in their portfolio include healthcare IT firms and technology-driven service providers. They emphasize long-term partnerships and are particularly interested in firms with strong EBITDA margins and scalable business models. For entrepreneurs, Chrysalis offers not just capital, but strategic guidance to help scale and optimize operations through the integration of new technologies.

Cigna Ventures, now operating as The Cigna Group Ventures, is the strategic corporate venture capital fund of The Cigna Group (NYSE: CI), one of the world's largest health service companies with over 190 million customer relationships across 30-plus countries. Founded in 2018 and based in Bloomfield, Connecticut, the firm received an initial $250 million capital commitment that enabled 19 direct investments, followed by an additional $450 million investment announced to drive healthcare transformation. With 44 investments made to date, the portfolio is organized around three pillars: insights and analytics, digital health and experience, and care delivery and enablement. Cigna Ventures deploys checks of $3 million to $30 million at the Series A through growth stages. Notable portfolio companies include Arcadia in population health management, AristaMD in eConsult platforms, Babyscripts in virtual maternity care, Buoy Health in AI health navigation, Cleerly in cardiac AI, Datavant in health data connectivity, Ginger in behavioral health, Omada in chronic condition management, and Prognos Health in clinical analytics. Managing Director Jasmi Shah leads the firm's ambition to be the strategic venture capital partner of choice for healthcare startups making care more affordable, simple, and predictable. The Cigna Group's massive customer base and integrated healthcare infrastructure give portfolio companies commercial pathways and validation that few other corporate venture investors in healthcare can match — making Cigna Ventures a strategically valuable partner for companies seeking both capital and accelerated market access.

CincyTech is a venture capital firm based in Cincinnati, Ohio, focusing on seed-stage investments to drive economic growth and innovation in the Midwest. Founded in 2006, CincyTech has invested in over 140 companies, particularly in the healthcare, technology, and life sciences sectors. Some of their notable investments include Enable Injections, which raised $215 million in Series C funding for their wearable drug delivery devices, and Genetesis, a company that secured $17.5 million to advance their Cardioflux diagnostic imaging platform. Other prominent portfolio companies include ReadySet Surgical, Standard Bariatrics, and NaviStone, which leverage innovative solutions in their respective fields. In 2022, CincyTech reported a record $391 million in co-investments in its portfolio companies, reflecting its significant impact on the regional economy. The firm continues to focus on partnering with visionary founders to transform ideas into world-class companies, supporting them with strategic guidance and access to a robust network of co-investors.

CircleUp Growth Partners, based in San Francisco, is a venture capital firm specializing in early-stage consumer brands. Their data-driven approach is powered by Helio, an advanced platform that provides comprehensive consumer market insights, enhancing the decision-making process for investments and supporting post-funding growth​. CircleUp has backed notable brands such as Halo Top Creamery, Back to the Roots, and Rhythm Superfoods, focusing on sectors like food and beverage, personal care, beauty, pet products, and household consumables​. CircleUp's investment strategy targets companies with revenues between $1 million and $20 million, typically providing growth equity ranging from $1 million to $10 million. They emphasize supporting visionary entrepreneurs who are passionate about their products and have a clear vision for their brands​. The firm is led by a team of experienced partners, including Sam Blumenthal and Karen Howland, who bring extensive backgrounds in consumer investing and operational support​ (CircleUp)​. CircleUp's holistic approach involves not just funding but also leveraging partnerships and community networks to foster collaboration and accelerate growth.

Cisco Investments, the corporate venture capital arm of Cisco, focuses on strategic investments in next-generation enterprise technologies. With over $2 billion in assets under management, Cisco Investments has a robust portfolio that includes companies specializing in AI/ML, cloud computing, cybersecurity, and IoT. Their investment strategy extends beyond financial backing, offering startups access to Cisco's vast network of experts, sales and marketing support, and a global customer base. One of their key initiatives is the Aspire Fund, a $50 million venture fund launched in 2020 to support diverse-led startups and venture funds. This fund specifically targets companies led by women and people of color, aiming to close the significant funding gap for these groups. Cisco Investments also partners with other venture funds such as Work-Bench and Acrew Capital to further their commitment to diversity and inclusion in the tech industry. The leadership team, including Janey Hoe, Derek Idemoto, and Prasad Parthasarathi, emphasizes a strategic approach to investment, integrating Cisco's innovation goals with their commitment to social justice and inclusion. This approach not only helps startups scale but also fosters a more inclusive tech ecosystem globally. Cisco Investments continues to be a driving force in the venture capital landscape, leveraging its strategic position and resources to support the growth and success of innovative startups across various technology sectors.

Citi Ventures, founded in 2008 and headquartered in San Francisco, is the venture capital arm of Citigroup. The firm focuses on strategic investments in innovative startups that have the potential to augment and enhance Citi's products and services. Citi Ventures invests across various sectors, including fintech, AI and data, commerce and payments, security and enterprise IT, customer experience and marketing, and proptech. Notable investments by Citi Ventures include significant names like Plaid, Square, DocuSign, Honey, and Cylance. The firm has a successful track record with exits, including six $1 billion-plus exits. Citi Ventures aims to invest in category-defining companies that can become leaders in their fields. Their investment strategy typically involves making initial investments ranging from $1 million to $20 million, with an average deal size of around $5 million. They often partner with other investors and lead approximately 20% of their new investments. Citi Ventures leverages Citigroup's global network to help portfolio companies scale and commercialize their innovations. About two-thirds of their portfolio companies have a relationship with Citibank, either through a pilot or full commercialization.

Citizen.VC is an online venture capital firm founded in 2013 and headquartered in Palo Alto, California. The firm operates as a principal investor in seed and Series A rounds while simultaneously running an online platform that enables accredited investors to co-invest alongside it in private companies. This dual model — combining direct investment with syndicated capital via special purpose vehicles — has earned Citizen.VC formal recognition from the SEC, which issued a no-action letter acknowledging its platform structure. The firm focuses on fintech, AI and data analytics, and health tech. Citizen.VC deploys checks in the $100,000 to $500,000 range at the seed and Series A stages, with follow-on capacity up to $2 million. Across 17 investments to date, the portfolio spans fintech, AI, health tech, and software applications. The platform model allows institutional-quality deal access to individual accredited investors, effectively democratizing entry to early-stage private company rounds that would otherwise be unavailable to them. Citizen.VC positions itself at the intersection of traditional venture and modern investment-platform technology. By aggregating capital from its network into SPVs, the firm can bring meaningful check sizes to founders while distributing risk and broadening the investor base. This approach reflects a thesis that the venture model itself benefits from structural innovation — using technology to open deal access without sacrificing the selectivity or conviction of a principal investor.

City Light Capital is an early-stage venture capital firm based in New York, focusing on investments that generate measurable social impact in the areas of education, safety and care, and the environment. They believe in leveraging private markets to address complex, intertwined social issues through scalable solutions. City Light invests in companies where financial success is directly tied to social impact, ensuring that growth in revenue equates to better lives at scale. The firm's portfolio includes a diverse array of impactful companies, such as Maven Clinic, Headspace Health, and OhmConnect, which provide solutions ranging from healthcare to clean energy. City Light typically invests between $50,000 and $3 million, often leading or co-leading rounds at the seed stage and beyond. They also have a dedicated seed investment program, City Spark, which nurtures early-stage companies with the potential for significant social impact. City Light's team is composed of experienced investors, including Partners Josh Cohen, Tom Groos, and Jeff Rinehart. They emphasize close collaboration with entrepreneurs to maximize both financial returns and social outcomes. The firm operates primarily in the United States, with a strong presence in major investment hubs like New York and the Midwest.

CIVC Partners is a private equity firm based in Chicago, specializing in investments in middle-market business services companies across the U.S. and Canada. With over $2 billion in equity capital under management, CIVC focuses on sectors such as utility and infrastructure services, insurance, transportation, IT, and tech-enabled services. The firm is known for its hands-on partnership approach, helping businesses scale through both organic growth and acquisitions. Founded in 1970, CIVC has a long history of investing in companies with EBITDA between $5 and $30 million, typically committing between $20 and $100 million per investment. The firm is heavily involved in recapitalizations, buyouts, and growth equity, leveraging its deep sector expertise to drive value creation. CIVC's investment philosophy centers on aligning closely with management teams to accelerate business growth. The team at CIVC is known for their long-standing collaboration, with an average of 20 years working together, contributing to their proven track record in scaling businesses across fragmented industries.

Civilization Ventures is a venture capital firm founded in 2017 with a strong focus on health tech and biology innovations. Based in Silicon Valley, the firm has grown from a $1M pilot seed fund to managing over $100M in capital. They have invested in over 60 companies across genomics, diagnostics, digital health, and synthetic biology, emphasizing preventative, personalized, and regenerative healthcare solutions. Notable investments include Rocket Pharma, which focuses on gene therapies for rare diseases, and Singular Bio, acquired by Invitae to enhance genetic screening in early pregnancy. Other significant exits include Lemonaid Health, acquired by 23andMe, and Rewrite, a gene editing company acquired by Intellia. The team at Civilization Ventures is composed of experienced biopharma executives and operators who have founded and sold companies. They support founders through a vast network and their extensive experience in the field. Additionally, they offer a unique fellowship program to train PhDs to become future entrepreneurs in the life sciences sector.

Claremont Creek Ventures is an Oakland, California-based seed and early-stage venture capital firm founded in 2005 by entrepreneurs Nat Goldhaber, John Steuart, and Randy Hawks. The firm manages more than $300 million across two funds and has backed over 40 companies. CCV concentrates on digital solutions with the potential to transform large, essential industries — particularly healthcare and energy — that have historically been slow to adopt emerging technologies such as mobility platforms, big data analytics, edge intelligence, and user-centric design. The firm leads the earliest investment rounds, typically committing $1 million to $10 million per company, and has deployed capital across 42 investments. Notable portfolio companies include Clean Power Finance, which pioneered solar financing; EcoATM, which built the automated electronic recycling kiosk network; and Natera, the genomic testing company that listed on NASDAQ. This track record across IPOs, acquisitions, and category-defining companies reflects CCV's focus on sectors where technology penetration remains incomplete. Claremont Creek practices what it calls Lifecycle Venturing — building relationships with entrepreneurs before or alongside early funding and preferring to be present when business concepts are still actively evolving. The team of six brings deep entrepreneurial and operating experience to each partnership, offering hands-on engagement at the stage when strategic input has the greatest leverage on long-term outcomes.

Claris Ventures is an Italian venture capital firm established in 2019, focusing on early-stage investments in high-potential biopharma companies. The firm's first fund, Claris Biotech I, targets innovations that are poised to enter clinical trials within 12 to 24 months. Claris Ventures is particularly interested in therapeutic areas such as oncology, immunology, and rare diseases—sectors that often have significant unmet medical needs. The firm's strategy involves not only providing capital but also offering hands-on support in areas like project management, finance, and strategic development, allowing scientific founders to focus on their research and development. Claris Ventures aims to build value around strong scientific evidence, with a mission to make a substantial impact on patient care. Claris Ventures leverages Italy's robust R&D ecosystem, drawing from local research centers, clinical institutions, and international collaborations. The team, led by Managing Partners Pietro Puglisi and Ciro Spedaliere, includes experienced professionals who are committed to guiding portfolio companies through the critical early stages of development. Some notable companies in their portfolio include NeoPhore, Resalis Therapeutics, and Kither Biotech, which are all working on breakthrough therapies in their respective fields.

Clave Capital is a prominent venture capital firm based in Pamplona, Spain, with a strong focus on the healthcare sector. Notable for their recent €50 million Clave Innohealth fund, they target high-growth potential startups across Europe, specifically in medtech, digital health, health-nutrition, and biotech sectors. Clave Capital’s portfolio includes promising startups like Innitius, which focuses on improving diagnostics for women’s health. Clave Capital primarily invests in early-stage to Series A funding rounds, with initial contributions ranging from €500k to €1 million, and potential follow-on investments up to €3 million per project. Their geographic focus extends throughout Spain and Europe. The firm’s investment strategy emphasizes not only financial backing but also active involvement in the growth and development of their portfolio companies. They maintain close relationships with research centers and hospitals, providing valuable expertise and connections to foster innovation. Clave Capital's experienced team, led by Chairman and CEO José Javier Armendariz and Director of Funds Santiago Lozano, has a track record of over 20 years and 90 investments, which positions them as a significant player in the European healthcare investment landscape. For startups looking to engage with Clave Capital, it’s advisable to highlight innovative potential and market leadership capabilities in the healthcare domain. Their preference for hands-on involvement means that demonstrating a collaborative approach could be beneficial.

Clay Capital, formerly known as VisVires New Protein, is a Singapore-based venture capital firm focused on agrifood technology. In 2023, the firm closed its second fund at $145 million, signaling a strong commitment to transforming the food and agriculture sectors. Clay Capital backs innovative startups across Europe, Asia, and Israel that are working to create sustainable and regenerative food systems. Its investment strategy targets technologies that address key issues like food security, sustainability, and environmental health. With initial investments ranging from $3 million to $8 million, Clay Capital supports startups working on solutions in areas such as regenerative agriculture, crop disease resistance, and sustainable packaging. The firm’s portfolio includes companies like Toopi Organics, which repurposes human urine as a bio-stimulant, and In Ovo, which develops sex determination technologies to reduce the culling of male chicks in the poultry industry. Clay Capital’s approach emphasizes connecting the Asian and European markets, leveraging its expertise and network to help startups expand globally. This cross-continental strategy reflects the firm’s vision of creating a healthier and more sustainable food system while fostering innovation in agrifood tech.

Cleo Capital is a venture capital firm founded in 2018 by Sarah Kunst, based in San Francisco, California. The firm focuses on early-stage investments, primarily targeting the pre-seed and seed stages. Cleo Capital is particularly committed to backing companies in sectors such as fintech, healthtech, web3, and the creator economy, with a key focus on three main investment theses: the Future of Income, Complicated Consumer, and Decentralized Enterprise. Cleo typically invests between $100K to $1M in startups with high growth potential, particularly those building software with the potential to become multi-billion-dollar enterprises. The firm has invested in over 40 companies, including notable startups like Ellevest, Kobold Metals, Hill House Home, and FalconX. As a general partner, Sarah Kunst is recognized as one of the top innovators in venture capital and has been involved in initiatives like Bumble Fund, advising underrepresented founders. Cleo Capital also places a strong emphasis on supporting entrepreneurs with long-term guidance and creating value within its portfolio.

Cleveland Avenue, founded in 2015 and based in Chicago, Illinois, is a venture capital firm that invests in lifestyle consumer brands and technology companies. The firm is dedicated to accelerating growth for entrepreneurs by providing not only financial resources but also strategic support across various business functions. Cleveland Avenue focuses on several sectors including food and beverage, AgTech, consumer goods, and health and wellness. Their portfolio includes innovative companies like Farmer’s Fridge, a vending machine company providing fresh meals; PreciTaste, an AI-enabled foodservice management platform; and Hero, a producer of zero-carb, zero-sugar foods made from plant-based proteins. The firm's approach goes beyond passive investment. They offer a range of services such as financial expertise, organizational development, marketing, supply chain optimization, and operational guidance to help their portfolio companies succeed. Their state-of-the-art Innovation Facility in Chicago serves as a hub for R&D, consumer research, and product showcases. Key figures at Cleveland Avenue include Don Thompson, the CEO, who leverages his extensive experience in corporate leadership to guide the firm's strategic vision, and Joseph McCoy, the COO and General Counsel, who brings a wealth of experience in legal and business transactions.

Climate Capital is an early-stage venture capital firm focused on investing in climate tech startups. Founded in 2018 by Sundeep Ahuja, Climate Capital aims to address climate change through strategic investments in innovative technologies that reduce emissions and promote climate adaptation. The firm supports over 350 teams working on various solutions, including clean energy production, carbon emission reduction, and sustainable lifestyle transformations. Climate Capital operates multiple funds and syndicates, such as the Seed, Growth, Bio, and Climate Scout Fund. This platform approach allows the firm to build expertise across specific verticals and leverage efficiencies of scale. The firm provides founders access to a wide network of partners, resources, and LPs to accelerate growth. Their portfolio includes companies like Mosaic, Moxion Power, and Ampaire, showcasing their commitment to diverse climate solutions. Climate Capital is highly networked, with over 2,500 climate investors, founders, operators, and enthusiasts in their community. This extensive network helps founders find talent, customers, strategic partners, and additional investors.

Cloud Capital is an India-based venture capital firm that specializes in funding early-stage startups in the cloud economy. Since its inception, Cloud Capital has deployed over $8 million across more than 50 startups, focusing on sectors like enterprise software, fintech, and vertical SaaS. The firm positions itself as an "operator-investor," meaning it provides not only capital but also strategic support, leveraging deep operational experience to help its portfolio companies scale effectively. Notable companies in Cloud Capital's portfolio include Kandle and Gold Setu, reflecting its commitment to backing innovative cloud-based and enterprise application startups. With a presence in India, the United States, and Singapore, Cloud Capital targets global growth markets while emphasizing technology-driven solutions. They typically invest in Seed and Series A rounds, with check sizes ranging from $500,000 to $5 million. The firm’s strategy is tailored to help startups through the critical early-stage phase, providing not just funding but also board-level guidance and a robust network of cloud industry executives. This hands-on Cloud Capital is a venture capital firm based in India, focused on funding early-stage startups within the cloud economy. The firm has deployed over $8 million across more than 50 companies, providing strategic guidance alongside its financial investments. Cloud Capital specializes in sectors such as enterprise software, fintech, and vertical SaaS, with a strong emphasis on startups leveraging cloud technology to scale. Founded by experienced operators, the firm offers more than just capital. Its "operator-investor" approach involves providing hands-on operational support, helping startups refine their business models, build their market presence, and scale effectively. Cloud Capital primarily invests in Seed and Series A rounds, with investments ranging from $500,000 to $5 million. The firm’s geographic focus includes India, the United States, and Singapore, with notable portfolio companies like Kandle and Gold Setu. Cloud Capital's network of industry experts and cloud executives offers portfolio companies access to valuable resources for growth and development. This positions Cloud Capital as a key player in supporting the next generation of cloud-based startups.

Cloudstone Venture Fund is a Redwood City, California-based venture capital firm founded in 2016 with a mission to improve the health and well-being of people globally. The firm was co-founded by Founding Partner Mark Zhang and General Partner Tom, and has since expanded its team for its second fund. Fund I comprises 24 investments, with 14 of those in healthtech companies — a concentration that reflects the firm's primary thesis from the outset. Cloudstone invests in technology startups across healthtech, AI, and software applications. The firm deploys seed and Series A checks ranging from $500,000 to $3 million per company. With 24 investments completed under Fund I, Cloudstone is raising Fund II with an exclusive focus on healthtech, narrowing the mandate to the sector where it has deepest experience. The portfolio spans digital health platforms, AI-enabled health tools, and software applications with applications in clinical and consumer wellness settings. Cloudstone's investment approach combines a mission-driven lens with commercial discipline — the belief that companies improving human health can also generate strong returns. The transition from a broad technology mandate in Fund I to a healthtech-only focus in Fund II signals growing conviction in the sector's depth and the team's ability to source and support the next generation of health technology companies.